<code id='CFC4065ED3'></code><style id='CFC4065ED3'></style>
    • <acronym id='CFC4065ED3'></acronym>
      <center id='CFC4065ED3'><center id='CFC4065ED3'><tfoot id='CFC4065ED3'></tfoot></center><abbr id='CFC4065ED3'><dir id='CFC4065ED3'><tfoot id='CFC4065ED3'></tfoot><noframes id='CFC4065ED3'>

    • <optgroup id='CFC4065ED3'><strike id='CFC4065ED3'><sup id='CFC4065ED3'></sup></strike><code id='CFC4065ED3'></code></optgroup>
        1. <b id='CFC4065ED3'><label id='CFC4065ED3'><select id='CFC4065ED3'><dt id='CFC4065ED3'><span id='CFC4065ED3'></span></dt></select></label></b><u id='CFC4065ED3'></u>
          <i id='CFC4065ED3'><strike id='CFC4065ED3'><tt id='CFC4065ED3'><pre id='CFC4065ED3'></pre></tt></strike></i>

          hotspot

          hotspot

          author:hotspot    Page View:5
          Allergan, Dom Smith/STAT

          It wasn’t supposed to work out this way for Brent Saunders.

          Four years ago, Saunders was the whiz kid of the pharmaceutical set. At 44, he had created a large pharmaceutical firm, then called Actavis, almost by force of will after engineering more than $100 billion in deals in a two-year span. Then he had swooped in to rescue Botox maker Allergan from the nefarious claws of Valeant Pharmaceuticals, an asset-stripping drug company loved by many on Wall Street but no one with a conscience.

          advertisement

          As CEO, he paired his dealmaking with a boyish charm and a willingness to take on big issues that made him seem like a potential spokesman for the whole industry.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Finland to offer bird flu vaccine to select groups of people, a possible global first
          Finland to offer bird flu vaccine to select groups of people, a possible global first

          H5N1birdfluparticlesCDCandNIAIDLONDON—Finlandispreparingtooffervaccinestopeopleatriskofexposuretoana

          read more
          State Dept. review finds Biden bears some blame for Afghanistan failures
          State Dept. review finds Biden bears some blame for Afghanistan failures

          3:53HundredsofpeoplegathernearaU.S.AirForceC-17transportplaneattheperimeteroftheinternationalairport

          read more

          'Little Tech' descents on D.C., wanting a say in how AI is regulated

          GarryTan,CEOofYCombinatorSebDaly/WebSummiWASHINGTON—InSanFrancisco,YCombinator’sfirebrandchiefexecut